| |
| |
|
| Insider
Information: |
Stejbach Mark |
| Relationship: |
Director |
| City: |
East Norriton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
79,728 |
|
|
Indirect Shares
|
1,580 |
|
|
| Direct
Value |
$1,233,220 |
|
|
|
Indirect Value
|
$14,410 |
|
|
| Total
Shares |
81,308 |
|
|
| Total
Value |
$1,247,629 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tengion Inc |
TNGN |
VP and Chief Commercia... |
2011-05-11 |
28,663 |
2010-04-09 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
SVP/Chief Comm Off, Al... |
2018-03-03 |
51,065 |
|
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2020-06-10 |
1,580 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2012-11-13 |
4 |
B |
$20.13 |
$24,156 |
D/D |
1,200 |
1,400 |
2.74 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2013-12-26 |
4 |
OE |
$17.30 |
$51,900 |
D/D |
3,000 |
4,400 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2014-01-15 |
4 |
OE |
$17.30 |
$48,094 |
D/D |
2,780 |
7,180 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2014-05-28 |
4 |
D |
$45.74 |
$37,232 |
D/D |
(814) |
8,866 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,680 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
11,678 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-03-03 |
4 |
D |
$72.80 |
$66,539 |
D/D |
(914) |
10,764 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-04-15 |
4 |
OE |
$17.30 |
$99,994 |
D/D |
5,780 |
16,544 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-04-15 |
4 |
D |
$62.83 |
$99,963 |
D/D |
(1,591) |
14,953 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
17,453 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-05-28 |
4 |
D |
$59.92 |
$48,715 |
D/D |
(813) |
16,640 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
21,640 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-10-05 |
4 |
D |
$59.77 |
$100,175 |
D/D |
(1,676) |
19,964 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-11-02 |
4 |
OE |
$17.30 |
$311,400 |
D/D |
18,000 |
37,964 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-11-02 |
4 |
AS |
$72.00 |
$1,297,168 |
D/D |
(18,000) |
19,964 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
19,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-12-01 |
4 |
AS |
$71.99 |
$1,299,209 |
D/D |
(18,000) |
19,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-12-01 |
4 |
OE |
$17.30 |
$311,400 |
D/D |
18,000 |
37,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-12-28 |
4 |
OE |
$17.30 |
$173,000 |
D/D |
10,000 |
29,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-12-28 |
4 |
AS |
$80.24 |
$802,392 |
D/D |
(10,000) |
19,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial OfficerOffice |
• – – |
2012-02-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200 |
|
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2017-06-16 |
4 |
B |
$17.02 |
$26,888 |
I/I |
1,580 |
1,580 |
2.1 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-05-26 |
4 |
B |
$9.75 |
$19,997 |
D/D |
2,051 |
2,051 |
2.39 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,551 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
12,631 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
